MEGABOSE MF 500 MG/0.3 MG TABLET

By Megabose MF

Rx

10 Tablet in a Strip

Composition icon

Composition

Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Aristo Pharmaceuticals Pvt Ltd icon

Manufacturer - Aristo Pharmaceuticals Pvt Ltd

Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.

Expires on or after icon

Expires on or after

October, 2025

About MEGABOSE MF 500 MG/0.3 MG TABLET

MEGABOSE MF 500 MG/0.3 MG TABLET is categorized as an anti-diabetic medication specifically designed to manage type 2 diabetes mellitus in adults. It plays a crucial role in regulating blood sugar levels for individuals diagnosed with diabetes. This medication is a combination of two key ingredients - Voglibose and Metformin. Voglibose, an alpha-glucosidase inhibitor, works by blocking certain enzymes in the intestines responsible for breaking down complex sugars into simple sugars like glucose. This mechanism helps prevent spikes in blood glucose levels. On the other hand, Metformin, a biguanide, acts by lowering serum glucose levels without increasing insulin secretion. It is unique in its ability to improve insulin sensitivity without causing hypoglycemia.

For optimal effectiveness, it is recommended to take MEGABOSE MF 500 MG/0.3 MG TABLET with food at consistent intervals as prescribed by your healthcare provider. The dosage may vary depending on individual blood sugar levels and response to the treatment. It is pivotal to follow the dosage instructions provided by your doctor to ensure the best outcome. While this medication is generally well-tolerated, it may present some common side effects such as nausea, changes in taste, stomach discomfort, diarrhea, and skin rash. If any of these side effects persist or cause concern, consulting your doctor is advised.

Prior to initiating treatment with MEGABOSE MF 500 MG/0.3 MG TABLET, it is crucial to inform your healthcare provider about any preexisting medical conditions, including anaemia, seizures, heart, kidney, or liver diseases. This medication does not typically lead to hypoglycemia, but when used alongside certain diabetic medications, there is a risk of low blood sugar levels. It is important to be cautious if following a restricted diet or fluid intake as MEGABOSE MF 500 MG/0.3 MG TABLET may cause dehydration and other complications. Individuals with gastrointestinal conditions like ulcerative colitis or Crohn’s disease should avoid this medication unless specifically directed by their doctor. It is imperative not to start or discontinue MEGABOSE MF 500 MG/0.3 MG TABLET without professional medical guidance. Regular monitoring of blood sugar levels and necessary tests are recommended to ensure the medication's safe and effective use.


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

45

Inclusive of all taxes

Content verified by

chevron-right

Dr. Abdullah Khan

MBBS - General Medicine

Last update on 01-Oct-2024